Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived— vs Q4 2017 Net Income-$98.90K-$98.90KderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$81,786N/M Operating Cash Flowderived-$50,028N/M ended Jul 31, 2018 · filed Dec 12, 2018 · 134 d after period end